With this contracting file whose conditions are established in the specifications, it is intended to cover the use of the medicine included in the file to meet the clinical needs of Osakidetza patients and related centers and which are summarized in the report's memory.

Active substance: fractional influenza virus or surface antigens.

Amount of active substance: vaccine according to WHO recommendations (northern hemisphere) and the European Union decision for the annual flu campaign; for adults and children from 6 months of age.

Pharmaceutical form: pre-filled syringe without needle.

Packaging conditions: unit dose.

Maximum unit price: EUR 2.95 / syringe.

Number of units planned: 450,000 syringes.

Maximum estimated budget: 1 327 500.00 EUR (first year of contract).